Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Palvella Therapeutics, Inc. (PVLA) had Weighted-Average Shares Outstanding (Diluted) of 11.01M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-8.19M |
|
-- |
|
-- |
|
$7.87M |
|
$-7.87M |
|
$-0.31M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-7.87M |
|
$-7.87M |
|
11.01M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
11.01M |
$-0.74 |
|
$-0.74 |
|
| Balance Sheet Financials | |
$79.44M |
|
-- |
|
-- |
|
$79.44M |
|
$8.98M |
|
-- |
|
$14.88M |
|
$23.86M |
|
$55.58M |
|
$55.58M |
|
$55.58M |
|
11.02M |
|
| Cash Flow Statement Financials | |
$-6.77M |
|
-- |
|
$-1.20M |
|
$83.60M |
|
$75.63M |
|
$-7.98M |
|
$1.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.73% |
|
-14.73% |
|
-10.30% |
|
-14.73% |
|
$5.04 |
|
$-0.61 |
|
$-0.61 |
|